1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Washington >
  6. Sanpower Group Co. Acquires Dendreon Pharmaceuticals  

M&A Deal Summary

Sanpower Group Co. Acquires Dendreon Pharmaceuticals  

On January 9, 2017, Sanpower Group Co. acquired life science company Dendreon Pharmaceuticals   from Bausch Health for 820M USD

Acquisition Highlights
  • This is Sanpower Group Co.’s 1st transaction in the Life Science sector.
  • This is Sanpower Group Co.’s largest (disclosed) transaction.
  • This is Sanpower Group Co.’s 1st transaction in the United States.
  • This is Sanpower Group Co.’s 1st transaction in Washington.

M&A Deal Summary
Date 2017-01-09
Target Dendreon Pharmaceuticals  
Sector Life Science
Buyer(s) Sanpower Group Co.
Sellers(s) Bausch Health
Deal Type Divestiture
Deal Value 820M USD

Target

Dendreon Pharmaceuticals  

Seattle, Washington, United States
Dendreon Pharmaceuticals, Inc. is a biotechnology company focused on targeting cancer and transforming lives through the discovery, development and commercialization of novel therapeutics that may significantly improve cancer treatment options for patients.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sanpower Group Co.

Jiangsu Province, China
Category Company
Founded 1993
Sector Diversified
DESCRIPTION

Sanpower Group has become one of the largest, privately-owned conglomerates in China. Headquartered in Nanjing, it offers a global platform for its five primary sector groups: Health & Wellness, Information Services, Consumer & Retail, Financial Services, and Real Estate. Sanpower Group has controlling stakes in more than 100 subsidiaries and has a 90,000-strong global workforce, including 30,000 based internationally.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Washington M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2017 M&A 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Bausch Health

Laval, Quebec, Canada
Category Company
Sector Life Science
Employees20,270
Revenue 9.6B USD (2024)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.

DEAL STATS #
Overall 4 of 10
Sector: Life Science M&A 2 of 3
Type: Divestiture M&A Deals 4 of 10
State: Washington M&A 1 of 1
Country: United States M&A 3 of 7
Year: 2017 M&A 1 of 6
Size (of disclosed) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-15 Synergetics USA

O’Fallon, Montana, United States

Synergetics USA, Inc. is a provider fo precision surgical devices.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-10 CeraVe

Bridgewater, New Jersey, United States

CeraVe is a developer and manufacturer of skincare products including cleansers, moisturizers, sunscreens and healing ointments.

Sell -
Mergr

Solution for

Product

Company

Legal